Deletion of tumor necrosis factor death receptor inhibits amyloid β generation and prevents learning and memory deficits in Alzheimer's mice
Open accessThe DOI matches its Crossref record; 75 of the 76 references it cites were found in a registry or an index.
Abstract
The tumor necrosis factor type 1 death receptor (TNFR1) contributes to apoptosis. TNFR1, a subgroup of the TNFR superfamily, contains a cytoplasmic death domain. We recently demonstrated that the TNFR1 cascade is required for amyloid β protein (Aβ)–induced neuronal death. However, the function of TNFR1 in Aβ plaque pathology and amyloid precursor protein (APP) processing in Alzheimer's disease (AD) remains unclear. We report that the deletion of the TNFR1 gene in APP23 transgenic mice (APP23/TNFR1−/−) inhibits Aβ generation and diminishes Aβ plaque formation in the brain. Genetic deletion of TNFR1 leads to reduced β-secretase 1 (BACE1) levels and activity. TNFR1 regulates BACE1 promoter activity via the nuclear factor-κB pathway, and the deletion of TNFR1 in APP23 transgenic mice prevents learning and memory deficits. These findings suggest that TNFR1 not only contributes to neurodegeneration but also that it is involved in APP processing and Aβ plaque formation. Thus, TNFR1 is a novel therapeutic target for AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures










Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several lines of evidence had linked the inhibition of TNF-α signaling with reduction of both Aβ and tau pathologies in vivo36,37.”
From New insights into the genetic etiology of Alzheimer’s disease and related dementias (2022) · cites this paper as [36]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
Death Receptors: Signaling and Modulation
Ashkenazi, A., & Dixit, V. M. (1998) · Science · doi:10.1126/science.281.5381.1305 · Cited by 5,866 · cited 1×
“The receptorinduced multimerization of a Fas-associated death domain protein leads to caspase activation, which causes degradation of specifi c target proteins, ultimately damaging cell integrity (Ashkenazi and Dixit, 1998).”
BackgroundVassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876
Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168
The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation
Hsu, H., Xiong, J., & Goeddel, D. V. (1995) · Cell · doi:10.1016/0092-8674(95)90070-5 · Cited by 2,012
Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective
Tanzi, R. E., & Bertram, L. (2005) · Cell · doi:10.1016/j.cell.2005.02.008 · Cited by 1,849
Skalli, O., Ropraz, P., Trzeciak, A., Benzonana, G., Gillessen, D., & Gabbiani, G. (1986) · The Journal of cell biology · doi:10.1083/jcb.103.6.2787 · Cited by 1,621
Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507 · cited 1×
“This might be because the APP transgene is controlled by different promoters in APP23 and Tg2576 mice (Irizarry et al., 1997; Sturchler-Pierrat et al., 1997).”
BackgroundSelf-citationFarris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E. A., Frosch, M. P., Eckman, C. B., Tanzi, R. E., Selkoe, D. J., & Guénette, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0230450100 · Cited by 1,286
Research works printed but not linked: 2
- 2003, Science., 299, 1014
- 2005, Med. Sci. Monit., 11, BR357
Cited by
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
New insights into the genetic etiology of Alzheimer’s disease and related dementias
Bellenguez, C., Küçükali, F., Jansen, I. E., Kleineidam, L., Moreno-Grau, S., Amin, N., Naj, A. C., Campos-Martin, R., Grenier-Boley, B., Andrade, V., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01024-z · Cited by 2,498
Inflammation as a central mechanism in Alzheimer's disease
Kinney, J. W., Bemiller, S. M., Murtishaw, A. S., Leisgang, A. M., Salazar, A. M., & Lamb, B. T. (2018) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.06.014 · Cited by 2,253
Role of Pro-Inflammatory Cytokines Released from Microglia in Neurodegenerative Diseases
Smith, J. A., Das, A., Ray, S. K., & Banik, N. L. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.10.004 · Cited by 1,165
Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases
Yuan, J., Amin, P., & Ofengeim, D. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0093-1 · Cited by 967
Inflammation in Alzheimer Disease--A Brief Review of the Basic Science and Clinical Literature
Wyss-Coray, T., & Rogers, J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006346 · Cited by 975
McCoy, M. K., & Tansey, M. G. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-45 · Cited by 847
Lee, J. W., Lee, Y. K., Yuk, D. Y., Choi, D. Y., Ban, S. B., Oh, K. W., & Hong, J. T. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-37 · Cited by 772
Evidence for a cytokine model of cognitive function
McAfoose, J., & Baune, B. T. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.10.005 · Cited by 760
“Despite these pathological implications (Bitsch et al., 2000; He et al., 2007), cytokines have also been shown to exert physiological (Blatteis, 1990; Sei et al., 1995; Vitkovic et al., 2000a) and even neuroprotective (Pan and Kastin, 2001; Schwartz et al., 1991, 1994) functions.”
BackgroundCytokine networks in neuroinflammation
Becher, B., Spath, S., & Goverman, J. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.123 · Cited by 697
Immune activation in brain aging and neurodegeneration: too much or too little?
Lucin, K. M., & Wyss-Coray, T. (2009) · Neuron · doi:10.1016/j.neuron.2009.08.039 · Cited by 679
“TNF-a is one such factor that has received much attention because of its ability to promote PD progression (McCoy et al., 2006), while TNF receptor 1 knockout protects against AD-and PD-like disease in mice (He et al., 2007; Sriram et al., 2002).”
BackgroundMinter, M. R., Zhang, C., Leone, V., Ringus, D. L., Zhang, X., Oyler-Castrillo, P., Musch, M. W., Liao, F., Ward, J. F., Holtzman, D. M., et al. (2016) · Scientific Reports · doi:10.1038/srep30028 · Cited by 655
Microglial cell dysregulation in brain aging and neurodegeneration
von Bernhardi, R., Eugenín-von Bernhardi, L., & Eugenín, J. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00124 · Cited by 556
Inflammation: the link between comorbidities, genetics, and Alzheimer’s disease
Newcombe, E. A., Camats-Perna, J., Silva, M. L., Valmas, N., Huat, T. J., & Medeiros, R. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1313-3 · Cited by 532
TNF and its receptors in the CNS: The essential, the desirable and the deleterious effects
Probert, L. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.06.038 · Cited by 495
Proteases and Proteolysis in Alzheimer Disease: A Multifactorial View on the Disease Process
De Strooper, B. (2010) · Physiological Reviews · doi:10.1152/physrev.00023.2009 · Cited by 455
“Further exploration of both pathways could yield viable drug targets for AD, not only to modulate BACE1 expression in a beneficial way, but also because of the potential neuroprotective and anti-inflammatory effects of this type of compounds (105, 258).”
BackgroundThe contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease
Minter, M. R., Taylor, J. M., & Crack, P. J. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13411 · Cited by 451
“Ablation of the TNFa receptor-1 in aged APP transgenic mice leads to a reduction in CD11b+ve reactive microglia in both cortical and hippocampal regions (He et al. 2007).”
BackgroundNeuroinflammatory processes in Alzheimer’s disease
Heneka, M. T., O’Banion, M. K., Terwel, D., & Kummer, M. P. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0438-z · Cited by 433
“For example, knockout of the TNF death receptor in APP23 mice leads to reduced expression of BACE1, reduced Ab production and deposition in APP23 mice (He et al. 2007).”
BackgroundInhibition of IL-12/IL-23 signaling reduces Alzheimer's disease–like pathology and cognitive decline
vom Berg, J., Prokop, S., Miller, K. R., Obst, J., Kälin, R. E., Lopategui-Cabezas, I., Wegner, A., Mair, F., Schipke, C. G., Peters, O., et al. (2012) · Nature Medicine · doi:10.1038/nm.2965 · Cited by 416
Microglia and Inflammation in Alzheimers Disease
Mandrekar-Colucci, S., & Landreth, G. E. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710791012071 · Cited by 421
Lourenco, M. V., Clarke, J. R., Frozza, R. L., Bomfim, T. R., Forny-Germano, L., Batista, A. F., Sathler, L. B., Brito-Moreira, J., Amaral, O. B., Silva, C. A., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.11.002 · Cited by 420
Varnum, M. M., & Ikezu, T. (2012) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-012-0181-2 · Cited by 394
“activators enhanced Ab clearance (He et al. 2007; Yamamoto et al. 2007, 2008).”
BackgroundFerreira, S. T., Lourenco, M. V., Oliveira, M. M., & De Felice, F. G. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00191 · Cited by 373
“Blocking TNFR1 signaling or alleviating brain ER stress through the use of chemical chaperones abrogate AβO-induced cognitive impairment (Lourenco et al., 2013), in accordance with findings in AD transgenic models (He et al., 2007; McAlpine et al., 2009; Ricobaraza et al., 2009, 2012).”
ResultTargeting Tumor Necrosis Factor Alpha for Alzheimer’s Disease
Decourt, B., Lahiri, D. K., & Sabbagh, M. N. (2017) · Current Alzheimer Research · doi:10.2174/1567205013666160930110551 · Cited by 371
Zhao, J., O'Connor, T., & Vassar, R. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-150 · Cited by 369
Montgomery, S. L., & Bowers, W. J. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9287-2 · Cited by 366
Apoptotic cell death in disease—Current understanding of the NCCD 2023
Vitale, I., Pietrocola, F., Guilbaud, E., Aaronson, S. A., Abrams, J. M., Adam, D., Agostini, M., Agostinis, P., Alnemri, E. S., Altucci, L., et al. (2023) · Cell Death & Differentiation · doi:10.1038/s41418-023-01153-w · Cited by 361
Neuroinflammatory TNFα Impairs Memory via Astrocyte Signaling
Habbas, S., Santello, M., Becker, D., Stubbe, H., Zappia, G., Liaudet, N., Klaus, F. R., Kollias, G., Fontana, A., Pryce, C. R., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.023 · Cited by 347
“Indeed, in animal models of AD, TNFα signaling via TNFR1 has been implicated in learning and memory deficits (He et al., 2007).”
González, H., Elgueta, D., Montoya, A., & Pacheco, R. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.07.012 · Cited by 352
Cai, Y., Liu, J., Wang, B., Sun, M., & Yang, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.856376 · Cited by 351
“, and neurotoxic substances, which is responsible for blocking neuronal differentiation, attenuating microglial phagocytosis, as well as extracellular matrix damage through the activation of nuclear factor kB and accumulation of Ab (37, 38).”
BackgroundBeyond the neuron–cellular interactions early in Alzheimer disease pathogenesis
Henstridge, C. M., Hyman, B. T., & Spires-Jones, T. L. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0113-1 · Cited by 348
Salminen, A., Kauppinen, A., Suuronen, T., Kaarniranta, K., & Ojala, J. (2009) · Journal of Neuroinflammation · doi:10.1186/1742-2094-6-41 · Cited by 329
Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer’s disease
Bairamian, D., Sha, S., Rolhion, N., Sokol, H., Dorothée, G., Lemere, C. A., & Krantic, S. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00522-2 · Cited by 314
Self-citationZhao, L., Wang, J.-L., Liu, R., Li, X.-X., Li, J.-F., & Zhang, L. (2013) · Molecules · doi:10.3390/molecules18089949 · Cited by 311
Alzheimer’s disease: pathological mechanisms and the beneficial role of melatonin
Rosales‐Corral, S. A., Acuña‐Castroviejo, D., Coto‐Montes, A., Boga, J. A., Manchester, L. C., Fuentes‐Broto, L., Korkmaz, A., Ma, S., Tan, D. X., & Reiter, R. J. (2012) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00937.x · Cited by 294
Lee, H. J., Lee, J. K., Lee, H., Carter, J. E., Chang, J. W., Oh, W., Yang, Y. S., Suh, J.-G., Lee, B.-H., Jin, H. K., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.03.024 · Cited by 283
“Several studies have indicated that neuroinflammatory reactions could contribute to BACE-1 expression (He et al., 2007; Lee et al., 2008; Sastre et al., 2003), and many also support the idea that neuroinflammation as a direct effect on A formation (Blasko et al., 1999; He et al., 2007; Lee et al.,…”
BackgroundJin, J.-J., Kim, H.-D., Maxwell, J. A., Li, L., & Fukuchi, K.-I. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-23 · Cited by 275
McAlpine, F. E., Lee, J.-K., Harms, A. S., Ruhn, K. A., Blurton-Jones, M., Hong, J., Das, P., Golde, T. E., LaFerla, F. M., Oddo, S., et al. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.01.006 · Cited by 268
“…6E10 and C9-immunoreactivity induced by chronic systemic inflammation Genetic deletion of the TNF receptor gene Tnfrsf1a in APP 23 transgenic mice was recently shown to result in reduction of both the number of amyloid plaques and the cognitive deficits in these mice (He et al., 2007).”
BackgroundRole of Microglia in Neurological Disorders and Their Potentials as a Therapeutic Target
Du, L., Zhang, Y., Chen, Y., Zhu, J., Yang, Y., & Zhang, H.-L. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0245-0 · Cited by 262
Astrocyte dysfunction in Alzheimer disease
Acosta, C., Anderson, H. D., & Anderson, C. M. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24075 · Cited by 247
“Amyloid b–induced astrocytic TNFa production (Johnstone et al., 1999) and TNFa silencing mitigated amyloid-dependent LTP suppression (Wang et al., 2005) and memory impairment (He et al., 2007; Alkam et al., 2008).”
BackgroundTNFα in synaptic function: switching gears
Santello, M., & Volterra, A. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.06.001 · Cited by 243
Astrocytes: Conductors of the Alzheimer disease neuroinflammatory symphony
Medeiros, R., & LaFerla, F. M. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2012.10.007 · Cited by 236
The roles of TNF in brain dysfunction and disease
Clark, I. A., Alleva, L. M., & Vissel, B. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.08.007 · Cited by 232
“In addition, TNFR1 depletion reduced BACE-1 activity (He et al., 2007).”
BackgroundResultInfluentialSu, F., Bai, F., & Zhang, Z. (2016) · Neuroscience Bulletin · doi:10.1007/s12264-016-0055-4 · Cited by 221
Shi, J.-Q., Shen, W., Chen, J., Wang, B.-R., Zhong, L.-L., Zhu, Y.-W., Zhu, H.-Q., Zhang, Q.-Q., Zhang, Y.-D., & Xu, J. (2011) · Brain Research · doi:10.1016/j.brainres.2010.10.053 · Cited by 219
“Knock-out of TNF-α receptor 1 prevents Aβ generation and learning deficits (He et al., 2007).”
BackgroundKiyota, T., Ingraham, K. L., Swan, R. J., Jacobsen, M. T., Andrews, S. J., & Ikezu, T. (2012) · Gene Therapy · doi:10.1038/gt.2011.126 · Cited by 217
Kiyota, T., Okuyama, S., Swan, R. J., Jacobsen, M. T., Gendelman, H. E., & Ikezu, T. (2010) · The FASEB Journal · doi:10.1096/fj.10-155317 · Cited by 212
The immunology of neurodegeneration
Czirr, E., & Wyss-Coray, T. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58656 · Cited by 213
Brambilla, R., Ashbaugh, J. J., Magliozzi, R., Dellarole, A., Karmally, S., Szymkowski, D. E., & Bethea, J. R. (2011) · Brain · doi:10.1093/brain/awr199 · Cited by 210
Lipocalin 2: Novel component of proinflammatory signaling in Alzheimer's disease
Naudé, P. J. W., Nyakas, C., E. Eiden, L., Ait‐Ali, D., van der Heide, R., Engelborghs, S., Luiten, P. G. M., De Deyn, P. P., den Boer, J. A., & Eisel, U. L. M. (2012) · The FASEB Journal · doi:10.1096/fj.11-202457 · Cited by 209
Inflammation context in Alzheimer’s disease, a relationship intricate to define
Novoa, C., Salazar, P., Cisternas, P., Gherardelli, C., Vera-Salazar, R., Zolezzi, J. M., & Inestrosa, N. C. (2022) · Biological Research · doi:10.1186/s40659-022-00404-3 · Cited by 206
“Contrarily, genetic deletion of IFNγ receptor was shown to reduce microglial activation and Aβ generation, together with the prevention of cognitive decline [34, 36].”
BackgroundTweedie, D., Ferguson, R. A., Fishman, K., Frankola, K. A., Van Praag, H., Holloway, H. W., Luo, W., Li, Y., Caracciolo, L., Russo, I., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-106 · Cited by 204
“These studies, together with others demonstrating that (1) TNF-α polymorphisms that elevate TNF-α production may increase AD risk, particularly in patients carrying one or more apolipoprotein E E4 alleles [46-49], and that (2) genetic ablation of TNF-α receptor 1 (TNFR1) in APP23 AD mice [50] or a selective lowering o…”
ResultTumor necrosis factor α Inhibition for Alzheimer’s Disease
Chang, R., Yee, K.-L., & Sumbria, R. K. (2017) · Journal of Central Nervous System Disease · doi:10.1177/1179573517709278 · Cited by 195
Jian, M., Kwan, J. S.-C., Bunting, M., Ng, R. C.-L., & Chan, K. H. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1492-6 · Cited by 188
Suppression of Alzheimer's Disease-Related Phenotypes by Expression of Heat Shock Protein 70 in Mice
Hoshino, T., Murao, N., Namba, T., Takehara, M., Adachi, H., Katsuno, M., Sobue, G., Matsushima, T., Suzuki, T., & Mizushima, T. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.5478-10.2011 · Cited by 183
“Therefore, we then examined the expression of cytokines that have been suggested to affect the phagocytosis of A (IL-1 , IL-6, TNF- , and TGF- 1) (WyssCoray et al., 2001; Tesseur et al., 2006; He et al., 2007; Hoshino et al., 2007b; Shaftel et al., 2007).”
BackgroundMicroglial Phenotype and Adaptation
Eggen, B. J. L., Raj, D., Hanisch, U.-K., & Boddeke, H. W. G. M. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9490-4 · Cited by 179
Inflammation and NF-κB in Alzheimer's Disease and Diabetes
Granic, I., Dolga, A. M., Nijholt, I. M., van Dijk, G., & Eisel, U. L. M. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-0976 · Cited by 173
Lysosomal storage diseases as disorders of autophagy
Settembre, C., Fraldi, A., Rubinsztein, D. C., & Ballabio, A. (2008) · Autophagy · doi:10.4161/auto.5227 · Cited by 173
Interactions between APP secretases and inflammatory mediators
Sastre, M., Walter, J., & Gentleman, S. M. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-25 · Cited by 171
Amyloid Deposition and Inflammation in APPswe/PS1dE9 Mouse Model of Alzheimers Disease
Ruan, L., Kang, Z., Pei, G., & Le, Y. (2009) · Current Alzheimer Research · doi:10.2174/156720509790147070 · Cited by 171
Chami, L., & Checler, F. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-52 · Cited by 168
Yang, H., Xie, Z. H., Wei, L. F., Yang, H. N., Yang, S. N., Zhu, Z. Y., Wang, P., Zhao, C. P., & Bi, J. Z. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt227 · Cited by 164
Role of TGFβ signaling in the pathogenesis of Alzheimer’s disease
von Bernhardi, R., Cornejo, F., Parada, G. E., & Eugenín, J. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00426 · Cited by 149
“…are involved in Aβ-mediated induction of NO and TNFα production by glia (O’Neill and Kaltschmidt, 1997; Akama et al., 1998; Saha et al., 2007; Munoz and Ammit, 2010), which correlates with Aβinduced cognitive impairment (Tran et al., 2001; Wang et al., 2005; He et al., 2007; Medeiros et al., 2007).”
BackgroundLiu, X., Hao, W., Qin, Y., Decker, Y., Wang, X., Burkart, M., Schötz, K., Menger, M. D., Fassbender, K., & Liu, Y. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.01.011 · Cited by 149
Treatment of TNF mediated diseases by selective inhibition of soluble TNF or TNFR1
Hauwermeiren, F. V., Vandenbroucke, R. E., & Libert, C. (2011) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2011.09.004 · Cited by 163
Schnöder, L., Hao, W., Qin, Y., Liu, S., Tomic, I., Liu, X., Fassbender, K., & Liu, Y. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.695916 · Cited by 148
Ma, T., Gong, K., Ao, Q., Yan, Y., Song, B., Huang, H., Zhang, X., & Gong, Y. (2013) · Cell Transplantation · doi:10.3727/096368913x672181 · Cited by 142
Pietri, M., Dakowski, C., Hannaoui, S., Alleaume‐Butaux, A., Hernandez-Rapp, J., Ragagnin, A., Mouillet‐Richard, S., Haïk, S., Bailly, Y. J. R., Peyrin, J., et al. (2013) · Nature Medicine · doi:10.1038/nm.3302 · Cited by 155
Zhang, J., Hu, M., Teng, Z., Tang, Y.-P., & Chen, C. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1165-14.2014 · Cited by 138
“We observed that Piog or rosiglitazone (ROS), another PPAR agonist, reduced BACE1 promoter activity, whereas TNF increased it (He et al., 2007).”
BackgroundSteeland, S., Libert, C., & Vandenbroucke, R. E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051442 · Cited by 156
Hampel, H., Lista, S., & Khachaturian, Z. S. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.05.2116 · Cited by 135
Progranulin Mutations as Risk Factors for Alzheimer Disease
Perry, D. C., Lehmann, M., Yokoyama, J. S., Karydas, A., Lee, J. J., Coppola, G., Grinberg, L. T., Geschwind, D., Seeley, W. W., Miller, B. L., et al. (2013) · JAMA Neurology · doi:10.1001/2013.jamaneurol.393 · Cited by 133
Heat-Shock Proteins in Neuroinflammation
Dukay, B., Csoboz, B., & Tóth, M. E. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00920 · Cited by 143
“In the APP23 transgenic mouse model of AD, suppression of the TNF-α receptor 1 diminished Aβ production and plaque formation by reducing BACE1 activity, which, in parallel, reduced diseaseassociated cognitive dysfunctions (He et al., 2007).”
BackgroundTargeting TNF: a therapeutic strategy for Alzheimer's disease
Cheng, X., Shen, Y., & Li, R. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.06.029 · Cited by 135
Self-citationNuclear receptors as therapeutic targets for Alzheimer's disease
Mandrekar-Colucci, S., & Landreth, G. E. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.594043 · Cited by 126
Upstream regulators and downstream effectors of NF-κB in Alzheimer’s disease
Shi, Z.-M., Han, Y.-W., Han, X.-H., Zhang, K., Chang, Y.-N., Hu, Z.-M., Qi, H.-X., Ting, C., Zhen, Z., & Hong, W. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.05.022 · Cited by 125
Alasmari, F., Alshammari, M. A., Alasmari, A. F., Alanazi, W. A., & Alhazzani, K. (2018) · BioMed Research International · doi:10.1155/2018/3087475 · Cited by 125
Thakker, D. R., Weatherspoon, M. R., Harrison, J., Keene, T. E., Lane, D. S., Kaemmerer, W. F., Stewart, G. R., & Shafer, L. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813404106 · Cited by 124
“We used a mouse monoclonal IgG1, 6E10, that recognizes the N terminus of human A and binds to the monomer, parenchymal plaques, and CAA (19, 32, 33).”
MethodInflammation and Anti-Inflammatory Strategies for Alzheimer’s Disease – A Mini-Review
McNaull, B. B. A., Todd, S., McGuinness, B., & Passmore, A. P. (2010) · Gerontology · doi:10.1159/000237873 · Cited by 123
Interruption of β-Catenin Signaling Reduces Neurogenesis in Alzheimer's Disease
He, P., & Shen, Y. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0421-09.2009 · Cited by 135
“The A ELISA was performed as described previously (He et al., 2007).”
MethodSelf-citationAnti-Apoptotic Effects of Carotenoids in Neurodegeneration
Park, H., Hayden, M. M., Bannerman, S., Jansen, J., & Crowe-White, K. M. (2020) · Molecules · doi:10.3390/molecules25153453 · Cited by 143
Modulation of inflammation in transgenic models of Alzheimer’s disease
Birch, A. M., Katsouri, L., & Sastre, M. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-25 · Cited by 121
Counteracting the effects of TNF receptor‐1 has therapeutic potential in Alzheimer's disease
Steeland, S., Gorlé, N., Vandendriessche, C., Balusu, S., Brkic, M., Van Cauwenberghe, C., Van Imschoot, G., Van Wonterghem, E., De Rycke, R., Kremer, A., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708300 · Cited by 121
“More-over, TNFR1 inhibition by a Nanobody recapitulated these findings Amyloidprecursor protein(APP) iscleavedintopathogenicamyloid-beta1 – 42(A b 1 – 42 )speciesbyBACE1,theexpressionofwhichcan beactivatedbyTNFR1-induced NF-j B in neurons of the hippocampus.”
InfluentialMedeiros, R., Figueiredo, C. P., Pandolfo, P., Duarte, F. S., Prediger, R. D. S., Passos, G. F., & Calixto, J. B. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.01.040 · Cited by 121
Chami, L., Buggia-Prévot, V., Duplan, E., Delprete, D., Chami, M., Peyron, J.-F., & Checler, F. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.333054 · Cited by 120
“In transgenic mice NF- B increases APP levels (43), BACE1promoter activity (44), expression (25, 45), and enzymatic activity (25, 43), -secretase activity (43); and A production (25, 43, 46).”
BackgroundMethodBuchhave, P., Zetterberg, H., Blennow, K., Minthon, L., Janciauskiene, S. M., & Hansson, O. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.10.012 · Cited by 140
Xu, J., & Ikezu, T. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-008-9136-0 · Cited by 119
“This result is bolstered by a genetic manipulation study in which genetic deletion of TNFR1 gene in APP23 transgenic mice inhibits Aβ generation and plaque formation in the brain via reduction of BACE1 levels and activity (He et al. 2007).”
BackgroundUllah, F., Liang, A., Rangel, A., Gyengési, E., Niedermayer, G., & Münch, G. W. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-1939-4 · Cited by 125
Tobinick, E. (2009) · CNS Drugs · doi:10.2165/11310810-000000000-00000 · Cited by 117
Hippocampal expression of murine TNFα results in attenuation of amyloid deposition in vivo
Chakrabarty, P., Herring, A., Ceballos-Diaz, C., Das, P., & Golde, T. E. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-16 · Cited by 117
Exploring ER stress response in cellular aging and neuroinflammation in Alzheimer's disease
Uddin, M. S., Yu, W. S., & Lim, L. W. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101417 · Cited by 135
Strategies to Target ADAM17 in Disease: From Its Discovery to the iRhom Revolution
Calligaris, M., Cuffaro, D., Bonelli, S., Spanò, D. P., Rossello, A., Nuti, E., & Scilabra, S. D. (2021) · Molecules · doi:10.3390/molecules26040944 · Cited by 130
“A lack of TNFR1 in a murine model of AD reduced plaque deposition microglia activation [136].”
BackgroundTNF and TNF receptors as therapeutic targets for rheumatic diseases and beyond
Siegmund, D., & Wajant, H. (2023) · Nature Reviews Rheumatology · doi:10.1038/s41584-023-01002-7 · Cited by 133
Shi, J., Zhang, C., Sun, X., Cheng, X., Wang, J., Zhang, Y., Xu, J., & Zou, H. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12066 · Cited by 115
p38 MAP Kinase Inhibitors as Potential Therapeutic Drugs for Neural Diseases
Yasuda, S., Sugiura, H., Tanaka, H., Takigami, S., & Yamagata, K. (2011) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/187152411794961040 · Cited by 115
Assessing the contribution of inflammation in models of Alzheimer's disease
Johnston, H., Boutin, H., & Allan, S. M. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390886 · Cited by 114
Woodling, N. S., Wang, Q., Priyam, P. G., Larkin, P. B., Shi, J., Johansson, J. U., Zagol-Ikapitte, I. A., Boutaud, O. G., & Andreasson, K. I. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0410-14.2014 · Cited by 130
“Inflammatory genes that were highly regulated in vitro, including iNOS, TNF- , COX-2, IRF1, and IRF7, were not differentially regulated in whole hippocampus at either age between nontransgenic and APP-PS1 mice, or between APPS-WT and APPS;EP4cKO mice (data not shown).”
BackgroundInfluentialAvila-Muñoz, E., & Arias, C. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.07.004 · Cited by 114
He, F., Qiu, B., Zhang, X.-H., Li, T., Xie, Q., Cui, D., Huang, X., & Gan, H. (2011) · Brain Research · doi:10.1016/j.brainres.2011.01.103 · Cited by 119
Blood–Brain Barrier Penetrating Biologic TNF-α Inhibitor for Alzheimer’s Disease
Chang, R., Knox, J., Chang, J., Derbedrossian, A., Vasilevko, V., Cribbs, D., Boado, R. J., Pardridge, W. M., & Sumbria, R. K. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00200 · Cited by 113
Metadata
- Authors
- He, P., Zhong, Z., Lindholm, K., Berning, L., Lee, W., Lemere, C., Staufenbiel, M., Li, R., & Shen, Y.
- Affiliations
- Banner Sun Health Research Institute (US)
- 1Haldeman Laboratory of Molecular and Cellular Neurobiology
- Brigham and Women's Hospital (US)
- Novartis (Switzerland) (CH)
- Corresponding author
- Shen, Yong
- Venue
- The Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2007-08-27
- Volume
- 178
- Issue
- 5
- Pages
- 829-841
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC2064547
- OpenAlex
- W2096277075
- Cited by
- 390
- References
- 76
- Citations by year
- 2026: 16 · 2025: 12 · 2024: 27 · 2023: 11 · 2022: 18 · 2021: 21 · 2020: 23 · 2019: 21 · 2018: 21 · 2017: 17 · 2016: 15 · 2015: 30 · 2014: 35 · 2013: 24 · 2012: 18
- FWCI
- 11.80
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Cell Biology (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (R01AG025888, AG025888)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- tumor necrosis factor receptor 1, Alzheimer's disease, amyloid-beta production, amyloid plaques, APP processing, beta-secretase 1, BACE1, NF-κB signaling, APP23 transgenic mice, learning and memory impairment, neurodegeneration, death receptor signaling
- MeSH terms
- Alzheimer Disease, Animals, Behavior, Animal, Disease Models, Animal, Gene Expression Regulation, Humans, Insulysin, Learning, Memory Disorders, Mice, Transgenic, Neurons, Promoter Regions, Genetic, Tumor Necrosis Factor-alpha, Neprilysin, Amyloid beta-Peptides, Aspartic Acid Endopeptidases, NF-kappa B, Cerebral Amyloid Angiopathy, Gene Deletion, Microglia, Mice, Knockout, Receptors, Tumor Necrosis Factor, Type I, Mice, Amyloid Precursor Protein Secretases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.